More Globe Newswire

View Older Stories View Newer Stories

Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Skyworks Solutions, Inc. of Class Action Lawsuit and Upcoming Deadlines - SWKS
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Constellation Brands, Inc. of Class Action Lawsuit and Upcoming Deadlines - STZ
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Lab USA, Inc. of Class Action Lawsuit and Upcoming Deadlines - RKLB
Apr 7, 2025 08:00AM HII Delivers Initial Lionfish SUUVs to U.S. Navy Under Multi-Year Program
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Trade Desk, Inc. of Class Action Lawsuit and Upcoming Deadlines - TTD
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FMC Corporation of Class Action Lawsuit and Upcoming Deadlines - FMC
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Edison International of Class Action Lawsuit and Upcoming Deadlines - EIX
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - TMDX
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Venture Global, Inc. of Class Action Lawsuit and Upcoming Deadlines - VG
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA
Apr 7, 2025 08:00AM Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ICON Public Limited Company of Class Action Lawsuit and Upcoming Deadlines - ICLR
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mullen Automotive, Inc. of Class Action Lawsuit and Upcoming Deadlines - MULN
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against SoundHound AI, Inc. and Certain Officers – SOUN
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against e.l.f. Beauty, Inc. and Certain Officers – ELF
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Alarum Technologies Ltd. and Certain Officers – ALAR
Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Elastic N.V. and Certain Officers – ESTC
Apr 7, 2025 08:00AM ONCAP Announces Final Close for ONCAP V
Apr 7, 2025 07:59AM Dimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
Apr 7, 2025 08:00AM ASML reports transactions under its current share buyback program
Apr 7, 2025 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Apr 7, 2025 08:00AM BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees
Apr 7, 2025 08:00AM JDE Peet’s share buyback periodic update April 7, 2025
Apr 7, 2025 08:00AM Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
Apr 7, 2025 08:00AM Michelin: 2024 UNIVERSAL REGISTRATION DOCUMENT
Apr 7, 2025 08:00AM LGI Homes Opens New Community in Orlando Area
Apr 7, 2025 07:59AM Libraries Offering Brain Exercises Can Become Centers for Brain Health
Apr 7, 2025 07:45AM Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025
Apr 7, 2025 07:42AM Transactions In Connection with Share Buy-back Program
Apr 7, 2025 07:42AM Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 04 04 2025] - (CGWL)
Apr 7, 2025 07:31AM ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial
Apr 7, 2025 07:30AM P10 Completes Acquisition of Qualitas Funds, a Leading European Lower-Middle Market Alternative Investment Solutions Provider
Apr 7, 2025 07:30AM Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Apr 7, 2025 07:30AM Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Apr 7, 2025 07:30AM Prime Drink Group Announces Its Intent to Acquire Relax Downlow, The Latest Brand to Collaborate with Lane Hutson
Apr 7, 2025 07:30AM TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
Apr 7, 2025 07:30AM Q-Gold Announces Appointment of Stan Bharti as Executive Chairman
Apr 7, 2025 07:30AM MariMed Promotes Ryan Crandall to Chief Commercial Officer
Apr 7, 2025 07:30AM Sulliden Acquires Portion of Nickel, Zinc, and Lead Mining Exploration Project in Poland
Apr 7, 2025 07:30AM NFI schedules release of first quarter 2025 financial results and provides details about Annual and Special Meeting of Shareholders
Apr 7, 2025 07:30AM Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression A
Apr 7, 2025 07:30AM Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Apr 7, 2025 07:30AM Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
Apr 7, 2025 07:30AM Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
Apr 7, 2025 07:30AM Bombardier to Report First Quarter 2025 Financial Results and Hold Annual General Meeting of Shareholders on May 1st, 2025
Apr 7, 2025 07:30AM MasterCraft Boat Holdings, Inc. Announces CFO Transition
Apr 7, 2025 07:30AM Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression Assoc
View Newer Stories View Older Stories